Cargando…

Correction: Tendler, M., et al. Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine. Trop. Med. Infect. Dis. 2018, 3, 121

Detalles Bibliográficos
Autores principales:	Tendler, Miriam, Almeida, Marília S., Vilar, Monica M., Pinto, Patrícia M., Limaverde-Sousa, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473639/ https://www.ncbi.nlm.nih.gov/pubmed/30669457 http://dx.doi.org/10.3390/tropicalmed4010016

Ejemplares similares

Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine
por: Tendler, Miriam, et al.
Publicado: (2018)

Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant
por: Tendler, Miriam, et al.
Publicado: (2015)

Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women
por: Santini-Oliveira, Marília, et al.
Publicado: (2022)

Correction: Nalin, D. Issues and Controversies in the Evolution of Oral Rehydration Therapy (ORT). Trop. Med. Infect. Dis. 2021, 6, 34
por: Nalin, David
Publicado: (2022)

Erratum: Pyke, A.T. et al. On the Home Front: Specialized Reference Testing for Dengue in the Australasian Region. Trop. Med. Infect. Dis. 2018, 3, 75
por: Pyke, Alyssa T., et al.
Publicado: (2019)

Correction: Malik et al. Integrated Tuberculosis and COVID-19 Activities in Karachi and Tuberculosis Case Notifications. Trop. Med. Infect. Dis. 2022, 7, 12
por: Malik, Amyn A., et al.
Publicado: (2022)

Correction: Perakanya et al. Prevalence and Risk Factors of Opisthorchis viverrini Infection in Sakon Nakhon Province, Thailand. Trop. Med. Infect. Dis. 2022, 7, 313
por: Perakanya, Pariyakorn, et al.
Publicado: (2023)

Correction: Srisuphanunt et al. Molecular Mechanisms of Antibiotic Resistance and Novel Treatment Strategies for Helicobacter pylori Infections. Trop. Med. Infect. Dis. 2023, 8, 163
por: Srisuphanunt, Mayuna, et al.
Publicado: (2023)

Correction: Sando E. et al. Serological Cross-Reactivity among Orientia tsutsugamushi Serotypes but Not with Rickettsia japonica in Japan. Trop. Med. Infect. Dis. 2018, 3, 74.
por: Sando, Eiichiro, et al.
Publicado: (2018)

Correction: Yuhana et al. Rickettsial Infections Are Neglected Causes of Acute Febrile Illness in Teluk Intan, Peninsular Malaysia. Trop. Med. Infect. Dis. 2022, 7, 77
por: Yuhana, Muhamad Yazli, et al.
Publicado: (2022)

Correction: Naimi, W.A., et al. Differential Susceptibility of Male versus Female Laboratory Mice to Anaplasma phagocytophilum Infection. Trop. Med. Infect. Dis. 2018, 3, 78
por: Naimi, Waheeda A., et al.
Publicado: (2019)

Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2
por: Pearson, Mark S., et al.
Publicado: (2012)

Correction: Srisuphanunt et al. Prognostic Indicators for the Early Prediction of Severe Dengue Infection: A Retrospective Study in a University Hospital in Thailand. Trop. Med. Infect. Dis. 2022, 7, 162
por: Srisuphanunt, Mayuna, et al.
Publicado: (2022)

VACS: VAccination disComfort Scale
por: Wallace, Manolis, et al.
Publicado: (2022)

GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
por: Clegg, Christopher H., et al.
Publicado: (2014)

The adjuvant GLA-AF enhances human intradermal vaccine responses
por: Carter, Darrick, et al.
Publicado: (2018)

Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults
por: Sagawa, Zachary K., et al.
Publicado: (2023)

Stressed stability and protective efficacy of lead lyophilized formulations of ID93+GLA-SE tuberculosis vaccine
por: Archer, Michelle C., et al.
Publicado: (2023)

Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons
por: Rojo, Juan U., et al.
Publicado: (2017)

Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer
por: Kushiyama, Shuhei, et al.
Publicado: (2021)

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE
por: Coler, Rhea N, et al.
Publicado: (2015)

The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for T(H)1 Induction
por: Cauwelaert, Natasha Dubois, et al.
Publicado: (2016)

Schistosomiasis—from immunopathology to vaccines
por: McManus, Donald P., et al.
Publicado: (2020)

SAT-121 Secretin Stimulation Test in a Patient Receiving Proton PUMP Inhibitor Therapy- to Do or Not to Do?
por: Madhavan, Parvathy, et al.
Publicado: (2020)

Une quatrième dose de vaccin pour tous ? Trop tôt pour le dire..
por: Dalmat, Yann-Mickael
Publicado: (2022)

Evolution of Matrix Gla and Bone Gla Protein Genes in Jawed Vertebrates
por: Leurs, Nicolas, et al.
Publicado: (2021)

Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
por: Choi, Yu Hwa, et al.
Publicado: (2023)

Developing anti-helminth vaccines for people and cattle: (For)seeing the one health approach in action
por: Tendler, Miriam, et al.
Publicado: (2023)

Schistosomiasis vaccine discovery using immunomics
por: Driguez, Patrick, et al.
Publicado: (2010)

Correction to: Schistosomiasis—from immunopathology to vaccines
por: McManus, Donald P., et al.
Publicado: (2020)

Trop petits pour Dieu /
por: Laederach, Monique, 1938-
Publicado: (1986)

Une trop bruyante solitude/
por: Hrabal, Bohumil, 1914-1997
Publicado: (1983)

Une fin trop précoce?
por: Rayson, Daniel
Publicado: (2022)

ScanBious: Survey for Obesity Genes Using PubMed Abstracts and DisGeNET
por: Tarbeeva, Svetlana, et al.
Publicado: (2021)

Myxoma of the Ovary: in Regard to Bedir et al. (Balkan Med J 2018;35:120-121)
por: Sterkers, Nicolas, et al.
Publicado: (2019)

DIS3L2 and LSm proteins are involved in the surveillance of Sm ring-deficient snRNAs
por: Roithová, Adriana, et al.
Publicado: (2020)

A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area
por: Diemert, David J., et al.
Publicado: (2023)

Highly Attenuated Vaccinia Virus Dis as a Potential Sars Vaccine
por: Ishii, Koji, et al.
Publicado: (2006)

Cysteine Peptidases as Schistosomiasis Vaccines with Inbuilt Adjuvanticity
por: El Ridi, Rashika, et al.
Publicado: (2014)

Development of Paramyosin as a Vaccine Candidate for Schistosomiasis
por: Jiz, Mario A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3mdfaebb0utdtq71n08onr2ijk